Multi-year clinical study data suggest use of FDA-cleared mobile ...

[Guest guest]

July 02, 2008

Business Wire - San Francisco,CA*

http://www.businesswire.com/portal/site/google/?

ndmViewId=news_view & newsId=20080702005467 & newsLang=en

Multi-year clinical study data suggest use of FDA-cleared mobile air

decontamination unit, PlasmairT2006 with HEPA-MD™, contributes to

reducing incidence of airborne aspergillosis infection

Data supports previously reported conclusions in December 2007 issue

of The Journal of Hospital Infection about the benefits of

AirInSpace mobile air filtration devices to help prevent outbreaks

of nosocomial infections related to construction work

WASHINGTON--(BUSINESS WIRE)--AirInSpace, a leading supplier of

mobile devices that `catch and inactivate' harmful and resistant

biological particles from the air, announced today that data from a

multi-year clinical study shows a significant reduction in

aspergillosis infection rates in a standard hospital setting when

using the Company's patented PlasmairT2006 mobile unit with HEPA-MD™

technology.

The data were presented by Ludwig Aho-Glélé, M.D., Director of

Infection Control and Hospital Epidemiologist at Dijon University

Hospital, a 1600-bed academic teaching hospital in Dijon, France,

during an educational symposium at the recent 2008 annual conference

of the Association for Professionals in Infection Control &

Epidemiology (APIC). The AirInSpace-sponsored symposium, " Strategies

for Airborne Infection Control Under Challenging Environments and

Patient Conditions " , also included presentations from S.

, M.D., Hospital Epidemiologist, Infection Prevention and

Control, New York University (NYU) Medical Center; and, Wayne R.

Thomann, Ph.D., Director, Occupational and Environmental Safety

Office, Duke University Health System.

" Invasive aspergillosis is a potentially deadly infection for immune-

suppressed hospital patients: the Centers for Disease Control and

Prevention (CDC) reports a mortality rate of 95 percent in immune-

suppressed patients who are recipients of allogeneic bone marrow

transplants and patients who have aplastic anemia, " said Dr. Aho-

Glélé. " These patients need a highly protective environment. Our

multi-year study demonstrates that the AirInSpace mobile system not

only can protect these patients but also is a less costly solution

for our hospital. "

Aspergillus is a genus of some 200, highly airborne molds, some of

which can be deadly, especially to immunocompromised hospital

patients. Incidence rates of invasive aspergillosis have been

reported as high as 26% in allogenic bone marrow transplant patients

and 25% in acute leukemia patients. And in these immunocompromised

patients who are infected by airborne aspergillosis spores, the

scientific literature reports that death occurs in as many as nine

out of 10 of these patients. The cost of extended hospitalization

from invasive aspergillosis is estimated to be as high as $49,336

per case.

" In a hospital setting, construction work that liberates large

amounts of Aspergillus spores is the major source of nosocomial

aspergillosis, " added Dr. Aho-Glélé. " Given that we have commenced a

major, long-term construction project right next door to high-risk

clinical units such as our adult and pediatric hematology wards, we

need to be extra diligent in preventing liberation of these spores

that are the source of potentially lethal nosocomial aspergillosis. "

AirInSpace's flagship product is an FDA-cleared mobile air-

decontamination unit called PlasmairT2006 by AirInSpace. Its

performance has been clinically proven to lower airborne biological

loads and is now being used to combat nosocomial infection in high-

risk areas of more than 100 hospitals and clinics, including

hematology/oncology units and ICUs. Developed initially for use in

Russia's MIR space station, the AirInSpace technology is in routine

use today on the International Space Station (ISS). AirInSpace owns

exclusive rights to this one-of-a-kind technology, which shows up to

99.999% single-pass inactivation of airborne microorganisms.

About AirInSpace

Headquartered in Sterling, Va., AirInSpace offers an innovative

range of products and services to address the need for microbial

decontamination of air in hospitals and other environments. For more

information, please visit www.airinspace.com, or contact the company

at: mail@....